Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ian A. Myles is active.

Publication


Featured researches published by Ian A. Myles.


Annals of Allergy Asthma & Immunology | 2011

Impulse oscillometry in the evaluation of diseases of the airways in children

Hirsh D. Komarow; Ian A. Myles; Ashraf Uzzaman; Dean D. Metcalfe

OBJECTIVE To provide an overview of impulse oscillometry and its application to the evaluation of children with diseases of the airways. DATA SOURCES Medline and PubMed search, limited to English language and human disease, with keywords forced oscillation, impulse oscillometry, and asthma. STUDY SELECTIONS The opinions of the authors were used to select studies for inclusion in this review. RESULTS Impulse oscillometry is a noninvasive and rapid technique requiring only passive cooperation by the patient. Pressure oscillations are applied at the mouth to measure pulmonary resistance and reactance. It is employed by health care professionals to help diagnose pediatric pulmonary diseases such asthma and cystic fibrosis; assess therapeutic responses; and measure airway resistance during provocation testing. CONCLUSIONS Impulse oscillometry provides a rapid, noninvasive measure of airway impedance. It may be easily employed in the diagnosis and management of diseases of the airways in children.


Journal of Immunology | 2013

Parental Dietary Fat Intake Alters Offspring Microbiome and Immunity

Ian A. Myles; Natalia M. Fontecilla; Brian M. Janelsins; Paul J. Vithayathil; Julia A. Segre; Sandip K. Datta

Mechanisms underlying modern increases in prevalence of human inflammatory diseases remain unclear. The hygiene hypothesis postulates that decreased microbial exposure has, in part, driven this immune dysregulation. However, dietary fatty acids also influence immunity, partially through modulation of responses to microbes. Prior reports have described the direct effects of high-fat diets on the gut microbiome and inflammation, and some have additionally shown metabolic consequences for offspring. Our study sought to expand on these previous observations to identify the effects of parental diet on offspring immunity using mouse models to provide insights into challenging aspects of human health. To test the hypothesis that parental dietary fat consumption during gestation and lactation influences offspring immunity, we compared pups of mice fed either a Western diet (WD) fatty acid profile or a standard low-fat diet. All pups were weaned onto the control diet to specifically test the effects of early developmental fat exposure on immune development. Pups from WD breeders were not obese or diabetic, but still had worse outcomes in models of infection, autoimmunity, and allergic sensitization. They had heightened colonic inflammatory responses, with increased circulating bacterial LPS and muted systemic LPS responsiveness. These deleterious impacts of the WD were associated with alterations of the offspring gut microbiome. These results indicate that parental fat consumption can leave a “lard legacy” impacting offspring immunity and suggest inheritable microbiota may contribute to the modern patterns of human health and disease.


Nature Immunology | 2013

Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus

Ian A. Myles; Natalia M. Fontecilla; Patricia A. Valdez; Paul J. Vithayathil; Shruti Naik; Yasmine Belkaid; Wenjun Ouyang; Sandip K. Datta

Staphylococcus aureus causes most infections of human skin and soft tissue and is a major infectious cause of mortality. Host defense mechanisms against S. aureus are incompletely understood. Interleukin 19 (IL-19), IL-20 and IL-24 signal through type I and type II IL-20 receptors and are associated with inflammatory skin diseases such as psoriasis and atopic dermatitis. We found here that those cytokines promoted cutaneous infection with S. aureus in mice by downregulating IL-1β- and IL-17A-dependent pathways. We noted similar effects of those cytokines in human keratinocytes after exposure to S. aureus, and antibody blockade of the IL-20 receptor improved outcomes in infected mice. Our findings identify an immunosuppressive role for IL-19, IL-20 and IL-24 during infection that could be therapeutically targeted to alter susceptibility to infection.Staphylococcus aureus causes the majority of human skin and soft tissue infections, and is a major infectious cause of mortality. Host defense mechanisms against S. aureus are incompletely understood. Interleukin (IL)-19, -20 and -24 signal through type I and type II IL-20 receptors and are associated with inflammatory skin diseases such as psoriasis and atopic dermatitis. We show here that these cytokines promote cutaneous S. aureus infection in mice by downregulating IL-1β- and IL-17A-dependent pathways. Similar effects of these cytokines were seen in human keratinocytes after S. aureus exposure, and antibody blockade of IL-20 receptor improved outcomes in infected mice. Our findings identify an immunosuppressive role for these cytokines during infection that could be therapeutically targeted to alter susceptibility to infection.


Nutrition Journal | 2014

Fast food fever: reviewing the impacts of the Western diet on immunity

Ian A. Myles

While numerous changes in human lifestyle constitute modern life, our diet has been gaining attention as a potential contributor to the increase in immune-mediated diseases. The Western diet is characterized by an over consumption and reduced variety of refined sugars, salt, and saturated fat. Herein our objective is to detail the mechanisms for the Western diet’s impact on immune function. The manuscript reviews the impacts and mechanisms of harm for our over-indulgence in sugar, salt, and fat, as well as the data outlining the impacts of artificial sweeteners, gluten, and genetically modified foods; attention is given to revealing where the literature on the immune impacts of macronutrients is limited to either animal or in vitro models versus where human trials exist. Detailed attention is given to the dietary impact on the gut microbiome and the mechanisms by which our poor dietary choices are encoded into our gut, our genes, and are passed to our offspring. While today’s modern diet may provide beneficial protection from micro- and macronutrient deficiencies, our over abundance of calories and the macronutrients that compose our diet may all lead to increased inflammation, reduced control of infection, increased rates of cancer, and increased risk for allergic and auto-inflammatory disease.


Cell Host & Microbe | 2012

Preserving Immunogenicity of Lethally Irradiated Viral and Bacterial Vaccine Epitopes Using a Radio-Protective Mn2+-Peptide Complex from Deinococcus

Elena K. Gaidamakova; Ian A. Myles; Dennis P. McDaniel; Cedar J. Fowler; Patricia A. Valdez; Shruti Naik; Manoshi Gayen; Paridhi Gupta; Anuj Sharma; Pamela J. Glass; Radha K. Maheshwari; Sandip K. Datta; Michael J. Daly

Although pathogen inactivation by γ-radiation is an attractive approach for whole-organism vaccine development, radiation doses required to ensure sterility also destroy immunogenic protein epitopes needed to mount protective immune responses. We demonstrate the use of a reconstituted manganous peptide complex from the radiation-resistant bacterium Deinococcus radiodurans to protect protein epitopes from radiation-induced damage and uncouple it from genome damage and organism killing. The Mn(2+) complex preserved antigenic structures in aqueous preparations of bacteriophage lambda, Venezuelan equine encephalitis virus, and Staphylococcus aureus during supralethal irradiation (25-40 kGy). An irradiated vaccine elicited both antibody and Th17 responses, and induced B and T cell-dependent protection against methicillin-resistant S. aureus (MRSA) in mice. Structural integrity of viruses and bacteria are shown to be preserved at radiation doses far above those which abolish infectivity. This approach could expedite vaccine production for emerging and established pathogens for which no protective vaccines exist.


PLOS ONE | 2014

Effects of Parental Omega-3 Fatty Acid Intake on Offspring Microbiome and Immunity

Ian A. Myles; Nathan B. Pincus; Natalia M. Fontecilla; Sandip K. Datta

The “Western diet” is characterized by increased intake of saturated and omega-6 (n−6) fatty acids with a relative reduction in omega-3 (n−3) consumption. These fatty acids can directly and indirectly modulate the gut microbiome, resulting in altered host immunity. Omega-3 fatty acids can also directly modulate immunity through alterations in the phospholipid membranes of immune cells, inhibition of n−6 induced inflammation, down-regulation of inflammatory transcription factors, and by serving as pre-cursors to anti-inflammatory lipid mediators such as resolvins and protectins. We have previously shown that consumption by breeder mice of diets high in saturated and n−6 fatty acids have inflammatory and immune-modulating effects on offspring that are at least partially driven by vertical transmission of altered gut microbiota. To determine if parental diets high in n−3 fatty acids could also affect offspring microbiome and immunity, we fed breeding mice an n−3-rich diet with 40% calories from fat and measured immune outcomes in their offspring. We found offspring from mice fed diets high in n−3 had altered gut microbiomes and modestly enhanced anti-inflammatory IL-10 from both colonic and splenic tissue. Omega-3 pups were protected during peanut oral allergy challenge with small but measurable alterations in peanut-related serologies. However, n−3 pups displayed a tendency toward worsened responses during E. coli sepsis and had significantly worse outcomes during Staphylococcus aureus skin infection. Our results indicate excess parental n−3 fatty acid intake alters microbiome and immune response in offspring.


JCI insight | 2016

Transplantation of human skin microbiota in models of atopic dermatitis

Ian A. Myles; Kelli W. Williams; Jensen D. Reckhow; Momodou L. Jammeh; Nathan B. Pincus; Inka Sastalla; Danial Saleem; Kelly D. Stone; Sandip K. Datta

Atopic dermatitis (AD) is characterized by reduced barrier function, reduced innate immune activation, and susceptibility to Staphylococcus aureus. Host susceptibility factors are suggested by monogenic disorders associated with AD-like phenotypes and can be medically modulated. S. aureus contributes to AD pathogenesis and can be mitigated by antibiotics and bleach baths. Recent work has revealed that the skin microbiome differs significantly between healthy controls and patients with AD, including decreased Gram-negative bacteria in AD. However, little is known about the potential therapeutic benefit of microbiome modulation. To evaluate whether parameters of AD pathogenesis are altered after exposure to different culturable Gram-negative bacteria (CGN) collected from human skin, CGN were collected from healthy controls and patients with AD. Then, effects on cellular and culture-based models of immune, epithelial, and bacterial function were evaluated. Representative strains were evaluated in the MC903 mouse model of AD. We found that CGN taken from healthy volunteers but not from patients with AD were associated with enhanced barrier function, innate immunity activation, and control of S. aureus. Treatment with CGN from healthy controls improved outcomes in a mouse model of AD. These findings suggest that a live-biotherapeutic approach may hold promise for treatment of patients with AD.


PLOS ONE | 2015

Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection.

Nathan B. Pincus; Jensen D. Reckhow; Danial Saleem; Momodou L. Jammeh; Sandip K. Datta; Ian A. Myles

The response to multi-drug resistant bacterial infections must be a global priority. While mounting resistance threatens to create what the World Health Organization has termed a “post-antibiotic era”, the recent discovery that antibiotic use may adversely impact the microbiome adds further urgency to the need for new developmental approaches for anti-pathogen treatments. Methicillin-resistant Staphylococcus aureus (MRSA), in particular, has declared itself a serious threat within the United States and abroad. A potential solution to the problem of antibiotic resistance may not entail looking to the future for completely novel treatments, but instead looking into our history of bacteriophage therapy. This study aimed to test the efficacy, safety, and commercial viability of the use of phages to treat Staphylococcus aureus infections using the commercially available phage SATA-8505. We found that SATA-8505 effectively controls S. aureus growth and reduces bacterial viability both in vitro and in a skin infection mouse model. However, this killing effect was not observed when phage was cultured in the presence of human whole blood. SATA-8505 did not induce inflammatory responses in peripheral blood mononuclear cultures. However, phage did induce IFN gamma production in primary human keratinocyte cultures and induced inflammatory responses in our mouse models, particularly in a mouse model of chronic granulomatous disease. Our findings support the potential efficacy of phage therapy, although regulatory and market factors may limit its wider investigation and use.


Seminars in Immunopathology | 2012

Staphylococcus aureus: an introduction

Ian A. Myles; Sandip K. Datta

Shortly after finishing his undergraduate studies at the University of Aberdeen in Scotland and embarking on his career as a surgeon, Alexander Ogston presented in 1880 at the Ninth Surgical Congress in Berlin his work establishing the causative role of bacteria in wound infection and subsequent septicemia. Building on the teachings of his senior contemporaries, Louis Pasteur and Joseph Lister, Ogston had observed pus from 88 human abscesses under his microscope and noted Gram-positive spherical “micrococci” [1]. Taking from the Greek word for “bunches of grapes,” he named the organism Staphylococcus. After injecting the isolated bacteria into healthy guinea pigs and mice and recreating the abscesses from which the isolates were derived, he had conclusively introduced the world to the infectious agent, now known as Staphylococcus aureus due to its golden color in culture, that continues to burden human health today [1].


BMC Microbiology | 2016

A method for culturing Gram-negative skin microbiota

Ian A. Myles; Jensen D. Reckhow; Kelli W. Williams; Inka Sastalla; Karen M. Frank; Sandip K. Datta

BackgroundCommensal Gram-negative (CGN) microbiota have been identified on human skin by DNA sequencing; however, methods to reliably culture viable Gram-negative skin organisms have not been previously described.ResultsThrough the use of selective antibiotics and minimal media we developed methods to culture CGN from skin swabs. We identified several previously uncharacterized CGN at the species level by optimizing growth conditions and limiting the inhibitory effects of nutrient shock, temperature, and bacterial competition, factors that may have previously limited CGN isolation from skin cultures.ConclusionsOur protocol will permit future functional studies on the influences of CGN on skin homeostasis and disease.

Collaboration


Dive into the Ian A. Myles's collaboration.

Top Co-Authors

Avatar

Sandip K. Datta

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Inka Sastalla

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Erik D. Anderson

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jensen D. Reckhow

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Kelli W. Williams

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Natalia M. Fontecilla

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ian N. Moore

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Mark D. Kieh

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Noah J. Earland

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Paul J. Vithayathil

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge